OLAPLEX is an innovative science-enabled and technology-driven beauty company. We are founded on the principle of delivering effective, patent-protected and proven performance in the categories where we compete. We strive to empower our consumers to look as beautiful on the outside as they feel on the inside. We believe every person deserves to have healthy […]

Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region. However, we shall not undertake our initial business combination with any entity with its principal business operations in China (including Hong Kong). (New blank-check company or SPAC incorporated in the British Virgin Islands) Our sponsor, Mr. Hooy […]

We are a commercial-stage medical technology and digital health company focused on developing comprehensive solutions to improve the health and quality of life of people with diabetes. We developed our first commercial product, the POGO Automatic Blood Glucose Monitoring System, or POGO Automatic, to revolutionize the blood glucose testing process for individuals living with diabetes. […]

Note: This is NOT an IPO. Amplitude, Inc., is offering shares of Class A common stock in a direct listing on the NASDAQ, with its stock expected to begin trading on or about Sept. 28, 2021. There are no underwriters. The financial advisors for the direct listing are Morgan Stanley, BofA Securities, Inc., Citigroup Global Markets […]

We intend to focus our search on industries that complement our management team’s background and to capitalize on the ability of our management team to identify and acquire a business focusing in the pharmaceutical and medical devices sectors, where our management team has extensive experience. (Note: Aesther Healthcare Acquisition Corp. priced its SPAC IPO on […]

(Note: This is a unit offering with KTTA as the proposed symbol for the common stock and KTTAW for the warrants.)  We are a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, […]

We intend to focus our search for a target business operating in data infrastructure and analytics, with a primary focus on space and wireless industries and related technology and services, which we refer to as “space-based tech” businesses. (Incorporated in the Cayman Islands)  (Note: Endurance Acquisition Corp. priced its SPAC IPO on Sept. 14, 2021, in […]

We intend to partner with a tech-enabled company based in the U.S. or Canada. We believe there are numerous partners operating in the technology and technology-enabled industries that are well-advantaged and highly scalable with the right guidance from an acquisition partner. We are targeting a company valued between approximately $1 billion and $5 billion that has a […]

We are a trusted global provider of value-added solutions to many of the world’s leading brands in the beauty, personal care and home care categories. We partner closely with both industry-leading consumer products companies and fast-growing independent brands as a critical enabler of their success through ideation, formulation, design, packaging and manufacturing of products sold […]

We intend to focus on operating businesses in and around the new energy, biotech, and education industries in Asia (excluding China). We shall not undertake our initial business combination with any entity with its principal business operations in China (including Hong Kong and Macau).